Aging is a privilege, but it also brings risks-including an increased likelihood of developing age-related diseases including ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

In a paper published in National Science Review, an international team of scientists report a coordination nanomedicine ...

"TGFB2 has emerged as a master regulator of immune suppression, not just in cancer but across multiple chronic diseases,” said Dr. Trieu. "Our work on OT-101 aims to neutralize TGFB2-driven resistance ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

Researchers have discovered a particular type of cancer cell that relies on its own biological electric utility company to thrive. Disrupting this power plant – with the help of a puffer fish – showed ...

Researchers at the Harvard Medical School discovered that the enzyme GUK1 promotes lung cancer growth by boosting the ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their elimination.

High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to ...